RxSight, Inc. Reports Second Quarter 2025 Financial Results
(NasdaqGM:RXST), ALISO VIEJO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) — (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended June 30, 2025. Key Company Highlights Reported second quarter 2025 revenue of $33.6 million, representing […]